Ann Lloyd, Pharm.D., BCPS-AQ ID

Clinical Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (918) -660-3027

Fax (918) -660-3009

Office SAC 2H34 - Schusterman Campus, Tulsa

Email ann-lloyd@ouhsc.edu


Summary

Program Director, PGY2 Infectious Diseases Residency



Education & Experience

Pre-Pharmacy Curriculum in Pre-Pharmacy

University of Kansas, Lawrence, KS

1999

Doctor of Pharmacy in Pharmacy

University of Kansas, Lawrence, KS

Distinction


2003

Pharmacy Practice Residency in Pharmacy

Barnes-Jewish Hospital at Washington University Medical Center, St. Louis, MO

2004


Publications & Presentations

1 2 > >>
  • Thiessen K, Lloyd A, Miller M J, Homco J, O'Neal K, Gildon B. Assessing guideline-concordant prescribing for community-acquired pneumonia. International Journal of Clinical Pharmacy. 2017
  • Lamb M M, Lloyd A. Necrotizing Soft-Tissue Infection: Disease Overview and Updated Treatment Strategies. US Pharmacist. 2017; 42 : HS16-HS20
  • Sharpton R, Condren M, McIntosh H, Lloyd A, O'Neal K. Do cystic fibrosis patients on azithromycin need electrocardiogram monitoring?. Pulmon Pharmacol Therap. 2017; 43 : 55-56
  • David C, O'Neal K, Miller M, Johnson J, Lloyd A. A literacy-sensitive approach to improving antibiotic understanding in a community-based setting. Pharmacotherapy. 2017; 7 : e83-e138
  • Sharpton R, Condren M, O'Neal K, Lloyd A, McIntosh H. QTc interval monitoring for chronic azithromycin therapy in patients with cystic fibrosis. Pediatric Pulmonology. 2016 : 353
  • 1 2 > >>